Hims & Hers Health Price to Book Ratio 2020-2023 | HIMS
Historical price to book ratio values for Hims & Hers Health (HIMS) over the last 10 years. The current price to book ratio for Hims & Hers Health as of May 10, 2024 is 8.04.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Hims & Hers Health Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2024-05-10 | 12.29 | 7.63 | |
| 2023-12-31 | 8.90 | $1.61 | 5.52 |
| 2023-09-30 | 6.29 | $1.55 | 4.06 |
| 2023-06-30 | 9.40 | $1.52 | 6.19 |
| 2023-03-31 | 9.92 | $1.49 | 6.64 |
| 2022-12-31 | 6.41 | $1.50 | 4.29 |
| 2022-09-30 | 5.58 | $1.50 | 3.73 |
| 2022-06-30 | 4.53 | $1.54 | 2.94 |
| 2022-03-31 | 5.33 | $1.59 | 3.35 |
| 2021-12-31 | 6.55 | $1.63 | 4.01 |
| 2021-09-30 | 7.54 | $1.74 | 4.33 |
| 2021-06-30 | 10.89 | $1.52 | 7.18 |
| 2021-03-31 | 13.23 | $1.53 | 8.66 |
| 2020-12-31 | 14.60 | $-2.77 | -5.27 |
| 2020-09-30 | 11.75 | $0.82 | 14.33 |
| 2020-06-30 | 10.17 | $0.85 | 11.94 |
| 2020-03-31 | 10.00 | $0.85 | 11.73 |
| 2019-12-31 | 9.90 | 0.00 | |
| 2019-09-30 | 9.87 | $0.82 | 11.98 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $2.768B | $0.872B |
| Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree Acquisition Corp., is based in San Francisco. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $37.763B | 20.73 |
| Inspire Medical Systems (INSP) | United States | $5.181B | 0.00 |
| Axonics (AXNX) | United States | $3.439B | 0.00 |
| 10x Genomics (TXG) | United States | $3.145B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.107B | 0.00 |
| Azenta (AZTA) | United States | $2.928B | 159.12 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.910B | 0.00 |
| Enovis (ENOV) | United States | $2.800B | 20.75 |
| Privia Health (PRVA) | United States | $2.139B | 120.20 |
| Schrodinger (SDGR) | United States | $1.673B | 0.00 |
| Omnicell (OMCL) | United States | $1.389B | 48.02 |
| Phreesia (PHR) | United States | $1.238B | 0.00 |
| Standard BioTools (LAB) | United States | $0.699B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.652B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.610B | 0.00 |
| Talkspace (TALK) | United States | $0.483B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.428B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.394B | 0.00 |
| Pulmonx (LUNG) | United States | $0.340B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.314B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.231B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.205B | 0.00 |
| Outset Medical (OM) | United States | $0.169B | 0.00 |
| American Well (AMWL) | United States | $0.152B | 0.00 |
| TruBridge (TBRG) | United States | $0.123B | 5.26 |
| Augmedix (AUGX) | United States | $0.122B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.120B | 0.00 |
| 111 (YI) | China | $0.095B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.073B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.071B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.060B | 0.00 |
| Zepp Health (ZEPP) | China | $0.054B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.046B | 0.00 |
| Movano (MOVE) | United States | $0.039B | 0.00 |
| Akili (AKLI) | United States | $0.035B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.033B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| CareCloud (CCLD) | United States | $0.021B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.021B | 0.00 |
| Cue Health (HLTH) | United States | $0.021B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| Biotricity (BTCY) | United States | $0.011B | 0.00 |
| Syra Health (SYRA) | United States | $0.009B | 0.00 |
| Transgenomic (PRPO) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.005B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.001B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |